Filing Details

Form Type:
4
Zero Holdings:
No
Publication Time:
2009-01-02 10:21:58
Reporting Period:
2008-12-31
Issuer
Cik Name Symbol Sector (SIC) IRS No
1009356 Salix Pharmaceuticals Ltd SLXP ()
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352546 Flynn James E Deerfield Capital Lp Deerfield Partners, Lp De 780 Third Avenue, 37Th Floor 780 Third A
37Th Floor 37Th Floor Columbus Centre, P
New York New York New York New NY 10017 1001
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2008-12-31 22,190 $8.87 3,935,661 No 4 P Indirect Through Deerfield International Limited
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Through Deerfield International Limited